Failure to Thrive Clinical Trial
Official title:
Growth and Development Longitudinal Follow-Up
1. Children in the home intervention group will have better growth (increase in weight and
height) than children in the control group.
2. Children in the home intervention group will have better behavior than children in the
control group.
3. Children in the home intervention group will have better academic performance than
children in the control group.
During the first years of life when energy needs are high, growth serves as an objective
measure of children's well-being. Failure-to-thrive (FTT) occurs when infants' rate of weight
gain is below expectations based on age and gender-specific growth charts. The proposed
randomized controlled trial evaluates whether a home-based intervention delivered by
community health workers is effective in altering patterns of children's growth and
development.
Infants were recruited from pediatric primary care clinics serving low-income, urban
communities from 1988 through 1993. Eligibility criteria included age < 25 months, at least
35 weeks gestational age and appropriate birth weight for gestational age, and no congenital
problems, disabilities, or chronic illnesses.
Children in the FTT group had to meet one of two criteria using age and gender-specific
National Center for Health Statistics (NCHS) growth charts: sustained weight-for-age below
the 5th percentile, weight-for-length below the 10th percentile or weight for age crossing
two major centiles and falling below the 25th percentile. All infants were examined by a
pediatrician, who also reviewed their medical charts to ensure that they met criteria for FTT
and there were no known syndromes or obvious major organ system dysfunctions, such as
congenital heart disease, to account for the growth failure of the infants in the FTT group.
Caregivers were invited to participate in a longitudinal research project, using consent
procedures approved by the Institutional Review Board of the University of Maryland,
Baltimore. Over 90% of eligible caregivers agreed and participated in an initial evaluation
that included measures of growth, standardized developmental assessments, and a 60-minute
interview of questionnaires on demographics, children's behavior, and maternal and family
functioning. Developmental assessments were administered by psychology graduate students,
supervised by a pediatric psychologist. A home visit was scheduled within two weeks of the
initial evaluation.
Children with FTT were treated in an interdisciplinary clinic. Based on a randomization
procedure, stratified by race, gender, and infant age to ensure equivalence across groups,
children with FTT were randomized to receive either the clinical intervention plus home
intervention (FTT-HI) or the clinical intervention only (FTT-CO).
The intervention was based on ecological theory and included a therapeutic alliance between
the interventionist and the caregiver; support to the caregiver's personal, family, and
environmental needs; opportunities to model and promote responsive parent-infant interaction;
and problem-solving strategies regarding personal, parenting, and children's issues. The
Hawaii Early Learning Program was used as a curriculum guide.
The intervention was delivered by three, part-time lay home visitors employed by a
community-based agency specializing in early intervention. The home visitors received an
eight-session training program and were supervised by a community health nurse. The home
visitors had portable mats and toys to demonstrate developmentally appropriate activities and
to facilitate parent-child interaction. They did not focus on nutrition or feeding behavior
and they did not weigh the children. One-hour visits were scheduled weekly for one year; the
number of visits varied from 0 to 47.
The children and caregivers return for regularly scheduled evaluations throughout the child's
life. Evaluators are unaware of their growth or intervention status. Caregivers provide the
name of the children's school and requests are sent for information on classroom behavior.
Families and teachers are compensated for participating in evaluations.
The outcome measures are growth, cognition, academic performance, and social behavior.
Evaluators are unaware of the children's growth history or group assignment. Standardized
measures are used.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05289674 -
The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
|
N/A | |
Completed |
NCT05333133 -
High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children
|
N/A | |
Completed |
NCT03202576 -
Nasogastric Tube Securement Comparison Study
|
N/A | |
Completed |
NCT01338363 -
Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
|
N/A | |
Completed |
NCT02879357 -
Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients
|
N/A | |
Completed |
NCT04393909 -
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
|
N/A | |
Not yet recruiting |
NCT01772927 -
Clinical Tolerance of Numeta 13%
|
N/A | |
Completed |
NCT02128984 -
Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children
|
N/A | |
Completed |
NCT01070173 -
Ghrelin Levels in Children With Poor Growth
|
N/A | |
Completed |
NCT00190658 -
Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome
|
Phase 3 | |
Completed |
NCT02647580 -
Appetite Regulation in Children With Failure to Thrive
|
N/A | |
Recruiting |
NCT01314989 -
Cyproheptadine as an Appetite Stimulant
|
Phase 4 | |
Completed |
NCT00001639 -
Evaluation of Patients With Unresolved Chromosome Abnormalities
|
N/A | |
Completed |
NCT04985227 -
Impact of Home Weight Tele-monitoring on the Number of Office Visits in the First Six Weeks of Life in Infants.
|
N/A | |
Terminated |
NCT02589132 -
Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive
|
N/A | |
Terminated |
NCT02710383 -
Biomarker for Cystic Fibrosis
|
||
Completed |
NCT00325611 -
Multidisciplinary Inpatient Palliative Care Intervention
|
N/A |